Synaptic Pharmaceutical Corporation

H. Lundbeck A/s

David Linemeyer

Richard L Weinshank

Theresa A Branchek

Carlos C Forray

Kelli E Smith

Christophe P G Gerald

Christophe P Gerald

This invention provides isolated nucleic acids encoding mammalian galanin receptors, isolated galanin receptor proteins, vectors comprising isolated nucleic acid encoding a mammalian galanin receptor, cells comprising such vectors, antibodies directed to a mammalian galanin receptor, nucleic acid probes useful for detecting nucleic acid encoding a mammalian galanin receptor, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding a mammalian galanin receptor, nonhuman transgenic animals which express DNA encoding a normal or a mutant mammalian galanin receptor, as well as methods of determining binding of compounds to mammalian galanin receptors.

Uses of galanin GALR2 receptors

Method of preparing GALR2 receptors composition

DNA encoding galanin GALR2 receptors

Method of identifying compounds that bind galanin receptor (GALR2)

This invention provides an isolated nucleic acid encoding a mammalian galanin receptor, an isolated galanin receptor protein, vectors comprising an isolated nucleic acid encoding a galanin receptor, cells comprising such vectors, antibodies directed to the galanin receptor, nucleic acid probes useful for detecting nucleic acid encoding galanin receptors, antisense oligonucleotides complementary to unique sequences of a nucleic acid encoding a galanin receptor, nonhuman transgenic animals which express DNA encoding a normal or a mutant galanin receptor, as well as methods of determining binding of compounds to the galanin receptor.

Method of identifying ligands which bind recombinant galanin receptor

Growing community of inventors

Guilford, CT, United States of America

David Linemeyer